Modal

Quick links to important sections

Modal

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Modal

Quick Facts

Property Description
Active ingredient Sulpiride
Forms Capsules, Tablets, Oral Solution, Injection
Pharmacological Class Neuroleptic Agent (Antipsychotic)
Common Use Stabilizing thought and emotional processes
Origin Synthetic Compound

What is Modal? Defining the Active Ingredient and Class

Modal is a prescription-only, single-ingredient medicine identified by its active substance, Sulpiride, a synthetic compound classified as a neuroleptic agent or antipsychotic. This classification places Modal within the category of drugs designed to modify chemical signaling within the central nervous system. The compound is specifically recognized as a benzamide derivative due to its core chemical structure, distinguishing it from older classes of antipsychotics. Pharmacological studies support its characterization as a chemically distinct neuroleptic agent that exhibits differences in its clinical effects compared to classical dopamine antagonists.


Understanding Modal's Pharmacological Identity

Modal is primarily known as a selective antagonist, meaning its main action involves regulating the activity of the key neurotransmitter, dopamine, in the brain. The Sulpiride molecule achieves this by attaching specifically to certain dopamine receptors, particularly the D2 and D3 types, effectively modulating the natural flow of information. This targeted function classifies it as an antidopaminergic agent. The drug's main mechanism involves the selective antagonism of central dopamine receptors. This action is essential to the drug's intended general therapeutic purpose, which is to help stabilize disturbed thought processes and intense emotional responses by helping to restore neural equilibrium, supporting its long-standing use in managing symptoms requiring emotional and mental stabilization.


Forms and Presentation of Sulpiride

The active ingredient Sulpiride is formulated for both oral and intramuscular routes of administration, ensuring flexibility for both acute and long-term management. Modal is available in several dosage form(s), including hard-shell capsules and compressed tablets for daily oral ingestion, as well as a sterile solution for intramuscular injection used when rapid therapeutic engagement is required. Variations such as Modal and Modal Forte exist to denote different concentrations of the same active substance.

What side effects are possible with Modal?

Modal (Sulpiride) is associated with a range of officially documented side effects, which are classified by regulatory authorities based on their reported frequency. The safety profile is structured across several System-Organ Classes (SOCs), primarily affecting the nervous, endocrine, and cardiovascular systems. Common adverse reactions, defined as occurring in at least 1 in 100 people, often include increased prolactin levels (hyperprolactinemia), weight gain, insomnia, sedation, and extrapyramidal symptoms such as tremor.


Serious Adverse Reactions and Safety Constraints

Official regulatory documents highlight rare but serious adverse reactions that require clinical attention. These include the potential for Neuroleptic Malignant Syndrome (NMS) and specific cardiac risks such as ventricular arrhythmias (including Torsade de Pointes) and sudden death, particularly in vulnerable patients. Safety restrictions explicitly document that Modal is contraindicated in individuals with pre-existing conditions like prolactin-dependent tumours and phaeochromocytoma.


Population and Time-Related Safety

Safety statements address specific populations, noting that older adults have a documented higher risk for effects like postural hypotension, sedation, and venous thromboembolism (VTE). For patients with renal impairment, dose adjustment and monitoring are officially required. Certain effects, such as persistent hyperprolactinemia and related sexual adverse reactions, are documented as being associated with long-term exposure to the medicine. These classifications establish the risk boundaries defined by governmental safety organizations.

Overdose and Emergency Response

Overdose and When to Seek Help

The information regarding overdose with Modal (Sulpiride) is derived from official regulatory documentation, emphasizing the need for immediate medical intervention due to the potential for severe complications.


Documented Clinical Manifestations

Official prescribing information states that overdose presentations can include a range of symptoms from restlessness, agitation, and confusion to severe CNS depression and coma. Neurological signs frequently documented are extrapyramidal symptoms, such as dystonia and trismus, along with convulsions and increased muscle tone. Cardiovascular effects often include hypotension and sinus tachycardia.


Severe Outcomes and Emergency Action

The regulatory profile highlights the risk of life-threatening cardiovascular events, particularly QT prolongation which can lead to Torsade de Pointes (TdP), cardiac arrest, and sudden death. Overdose also carries the potential for Neuroleptic Malignant Syndrome (NMS). Due to these risks, the official label mandates that the user seek immediate medical attention upon suspicion of overdose.


Management and Monitoring

No specific antidote is known for Sulpiride overdose; therefore, management is defined as symptomatic and supportive treatment. Close medical monitoring is required, focusing specifically on cardiac function to observe for signs of long QT syndrome and severe arrhythmias.

Therapeutic Uses of Modal

What Modal Treats: Main Uses and Benefits

Modal (Sulpiride) is a prescription medicine applied across domains where additional symptomatic support is needed and emotional stabilization is relevant. It is generally used to address symptoms that create noticeable functional strain, helping to contribute to easing the overall symptom load during acute and chronic manifestations. It is commonly used in situations involving certain distressing symptoms, relevant in conditions characterized by periods of heightened symptoms, and is applied in addressing symptom clusters that may become intense or disruptive in children.

The medication is commonly used when symptoms become temporarily overwhelming, such as episodes of intense behavioral restlessness and agitation. It is also relevant for easing symptoms related to systemic imbalance, such as vertigo (dizziness), and helps manage the symptom clusters associated with persistent low mood. This provides helpful symptomatic assistance and assists with maintaining functional stability when symptoms are more noticeable.

“The medication helps to offer symptomatic relief that helps patients cope more steadily with challenging symptom fluctuations.”

Quick Fact: Relief for Key Symptoms
Modal is relevant for managing symptoms that interfere with daily comfort, such as delusions, hallucinations, apathy, and persistent low mood, and supports patients during episodes of heightened discomfort related to agitation or vertigo.

Eligibility and Restrictions for Use

Modal (Sulpiride) eligibility is strictly defined by regulatory authorities and is determined by patient diagnosis, physiological status, and co-existing health conditions. Use is generally established for adult patients but is subject to several restrictions and absolute contraindications.

Absolute Contraindications (Must Not Use)

The medicine is formally prohibited for individuals with:

  • Hypersensitivity to sulpiride or its excipients.
  • Prolactin-dependent tumours (e.g., pituitary prolactinoma or breast cancer).
  • Phaeochromocytoma (adrenal gland tumour) or Acute Porphyria.
  • Concomitant use of Levodopa or other dopaminergic anti-Parkinsonian drugs (e.g., ropinirole).

Age-Group and Condition Restrictions

Population Group Eligibility Status Restrictions/Caution
Children under 14 Not Recommended Insufficient clinical experience established in this age group.
Older Adults (Geriatric) Use with Particular Caution Increased susceptibility to effects and risk of death if used for dementia-related behavioural disturbances (for which it is not licensed).
Pregnancy/Lactation Not Recommended Limited data for use during pregnancy; excreted into breast milk during lactation.
Renal Impairment Restricted Use A mandatory dose reduction is required, as the drug is primarily eliminated by the kidneys.
Cardiovascular Risk Use with Caution Advised for patients with a predisposition to QT interval prolongation (e.g., hypokalaemia or bradycardia) or risk factors for stroke.
Neurological Risk Use with Caution Advisable for patients with a history of epilepsy or seizures, due to a potential lowering of the seizure threshold.

What should I know about interactions with other medicines?

Modal Interactions with other medicines and products

This section describes the formally documented interaction patterns of Modal (Sulpiride), focusing strictly on classifications and constraints defined in authoritative regulatory labeling.


Contraindications and Core Restrictions

Co-administration with Levodopa and other dopaminergic antiparkinsonian agents (such as Ropinirole) is formally contraindicated by regulatory agencies due to reciprocal antagonism of effects. Combinations with drugs that prolong the QT interval or induce risk factors for serious ventricular arrhythmias (Torsades de Pointes) are severely restricted. These agents include Class Ia and Class III antiarrhythmics, as well as products that cause bradycardia or hypokalemia.


Exposure and Timing Constraints

The co-administration of Antacids (containing Aluminium or Magnesium salts) and Sucralfate is documented to cause decreased absorption of Sulpiride, which reduces systemic exposure. This absorption interference requires an administration-timing rule: Sulpiride must be taken two hours before these products. Unlike many medications, Sulpiride is not substantially metabolized by the Cytochrome P450 system, minimizing the risk of CYP-mediated metabolic interactions.


Additive Pharmacodynamic Effects

The official labeling notes several additive pharmacodynamic effects. Co-use with Alcohol or other CNS depressants (including Benzodiazepines and Narcotics) enhances the sedative effect. The combination with Antihypertensive Agents may enhance postural hypotension, and co-use with Lithium increases the risk of extrapyramidal effects.

Mechanism of Action

Modulation of Receptor-Mediated Signaling

Modal acts within specific physiological systems by initiating or suppressing key signaling sequences through interaction at the receptor level. This modification of early molecular steps results in changes to baseline physiological pathway activity and influences the drug's action profile.


Regulation of Dysregulated Pathway Activity

The drug engages mechanisms that influence feedback regulation within pathways, specifically targeting activity that may escalate under certain conditions. By affecting systems where targeted pathway adjustment is required, Modal modulates the activity of overactive or dysregulated processes.


Influencing Rapid Physiological Adjustments

Modal is relevant in cascades where multiple layers of pathway activation occur, altering the rate or intensity of signal propagation. This mechanism reduces the concentration or signaling duration of mediators and produces measurable adjustments in physiological pathway outputs.

Dosage and Administration Information

How to Use Modal (Sulpiride) – Official Administration Guidelines

Modal, identified by the active ingredient Sulpiride, is officially formulated for oral administration—available as tablets and solution—and as a sterile solution for intramuscular injection. The standard adult oral regimen involves administering the dose in two divided doses daily (twice daily), typically in the morning and early evening.

Dosing and Frequency

Adult dosing begins within a typical total daily range of 400 mg to 800 mg. Depending on the required therapeutic pattern, this dose may be titrated up to a maximum labeled daily dose of 2400 mg, which is administered as 1200 mg twice daily.

Administration and Handling

Oral tablets must be swallowed whole with a sufficient amount of water. A critical administration constraint is timing: Sulpiride should be taken at least two hours before any antacids containing aluminum or magnesium, as these agents interfere with its absorption. The initiation of treatment often requires supervision by a specialist under whose regular care the patient remains.

Population-Specific Adjustments

Official instructions mandate that the dose must be reduced in patients with established renal impairment. These necessary adjustments to the dose or interval are determined based on the patient's creatinine clearance level. Furthermore, the medicine is not recommended in children under 14 years of age.

Treatment Tapering

Treatment with Modal should not be stopped abruptly. The dose must be gradually lowered (tapered) under supervision when discontinuation is planned. If a dose is forgotten, the official instruction is to skip the missed dose and continue with the regular schedule, without taking a double dose to compensate.

Recent Clinical Evidence

Research evidence / Overview of Studies for Modal (Sulpiride)

This overview describes the research landscape and types of studies that have been conducted for Modal, focusing only on the official scientific evidence and regulatory summaries. The findings below reflect group patterns observed in research studies.


Evidence for Stabilization of Thought and Emotional Processes

Research explored the monitoring of changes in symptom evolution in conditions characterized by fluctuating or episodic manifestations. These studies primarily include short-term Randomized Controlled Trials (RCTs) and older comparative research. These trials were applied in research contexts involving fluctuating or unstable symptoms in adult populations, including both those in hospital settings and outpatients.

Research monitored outcomes such as changes in overall global status and the measurement of symptom severity scores. Systematic reviews of this evidence note that reported outcomes were short-term and based on populations where sample sizes were modest. Discontinuation rates were also observed.


Evidence for Specific Symptom Clusters Studied

Separate research has explored Sulpiride's role in specific symptom clusters.

Research explored the effects on symptoms related to persistent low mood or depressive syndrome in short-term, placebo-controlled trials involving adult outpatients. Studies monitored changes in established depression rating scales typically over about six weeks. Comparative evidence is lacking against many contemporary antidepressant therapies, and results apply only to the populations studied.

Additionally, research examined outcomes related to symptoms such as apathy or anergia (often called negative symptoms). Evidence quality varies across studies, and many of the trials examining this specific cluster were relatively small. Certainty remains low regarding consistent findings for these specific symptom scores, and data for certain groups remain insufficient.


What Research Gaps and Uncertainty Remain

The overall certainty remains low for certain findings due to factors consistently noted in systematic reviews.

Key Research Limitations include the fact that results apply only to the populations studied, and that follow-up durations were limited across many pivotal trials. Specifically, there is limited information for long-term outcomes related to functional recovery and sustained stability. Comparative evidence against many modern treatments is lacking, and data for certain age or comorbidity groups remain insufficient.

Key Studies & References Improvement of vestibular compensation by Levo-Sulpiride in acute unilateral labyrinthine dysfunction

Frequently Asked Questions (FAQ)

Common questions about Modal (FAQ)

Q: What is the difference between Modal and [similar drug]?

A: Official information characterizes Modal's active ingredient, Sulpiride, as a benzamide derivative. It is classified as a selective antagonist, meaning it specifically works on certain dopamine receptors (D2 and D3 types) to modulate signaling. This specific mechanism is what scientifically distinguishes it from other classes of neuroleptic agents.

Q: Can Modal be used for conditions other than its primary listed use?

A: The official product information and labeling strictly define the approved therapeutic indications for which Modal has been studied and licensed. Official materials only provide factual information for the documented, approved uses. Any use outside of these defined indications is considered a matter of clinical judgment by the prescribing physician.

Q: Is Modal safe to take every day for a long period of time?

A: Regulatory documents indicate that Modal treatment is often continued over long periods and is typically continued, with changes decided based on professional assessment. Official information notes that some side effects, such as increased prolactin levels, are specifically associated with prolonged exposure to the medicine. Discontinuation or modification of long-term use is based on ongoing assessment by a healthcare professional.

Q: Can Modal cause drowsiness or affect my ability to drive?

A: Yes, official warnings state that the medicine can cause sedation, which is a common side effect. Because of the risk of drowsiness, the ability to safely drive vehicles or operate machinery may be impaired. Patients are cautioned against performing these activities if they feel sleepy or less alert after taking the medicine.

Q: Are there any specific foods or drinks that should be avoided while taking Modal?

A: Official instructions explicitly advise against drinking alcohol while using Modal, as this can increase the risk of side effects, including enhanced sedative effects. The official product information focuses on drug-drug interactions, such as taking the medicine two hours before antacids, and generally does not specify common food restrictions.

Q: Why do some people say Modal 'didn't work' for them?

A: Individual responses to any medicine can vary, and official documents acknowledge that the ideal dose can be highly dependent on individual needs and the specific symptoms being treated. The studies conducted also focused on specific populations, and results may not perfectly translate to every patient.

Q: Does Modal affect birth control pills or other hormonal medications?

A: Yes, official reports document that Modal can commonly cause an increase in the hormone prolactin (hyperprolactinemia). This hormonal change may result in gynecological effects such as irregular or absent menstrual periods, and potential impact on reproductive health.

Q: Is it normal to feel a change in appetite when starting Modal?

A: Official adverse reaction reports list weight gain as a common side effect associated with the medicine. While the change in appetite is not explicitly listed, weight gain is a documented physical change that suggests a change in metabolism or eating patterns may occur.

Q: Are there specific symptoms that mean I should stop taking Modal immediately?

A: Official patient safety information requires immediate medical contact for specific severe symptoms. These include a high fever, muscle stiffness, confusion, or a fast heartbeat, as these can be signs of the rare but serious Neuroleptic Malignant Syndrome. The general instruction for stopping the medicine is to consult a professional first to prevent adverse effects.

Q: What should I do if I accidentally take two doses of Modal too close together?

A: In the event of an accidental overdose or taking the medicine too close together, official guidance is to contact a doctor, emergency services, or pharmacist immediately for advice. This confirms that taking more than the prescribed amount is a situation requiring prompt professional intervention.

Q: Does Modal require special monitoring or blood tests?

A: Yes, official regulatory documents require careful monitoring during treatment. Patients may need occasional tests to check things like heart rhythm (QT interval), kidney function (for dose adjustment), and prolactin levels, as part of the overall treatment plan.

Q: Does Modal interact with common over-the-counter pain relievers?

A: Official patient safety information advises checking with a healthcare professional or pharmacist regarding all over-the-counter medicines. This general advice confirms that common pain relievers are relevant to the drug's safety profile and should be discussed due to potential interactions.

Q: Is Modal considered a 'new' drug, or has it been around for a while?

A: The active ingredient, Sulpiride, is an established pharmacological compound. Regulatory-adjacent scientific literature indicates the substance was first described in the mid-20th century, confirming it is not considered a newly developed drug.

Q: Can Modal be taken by someone who has liver problems?

A: Official pharmacological data indicates that the medicine is poorly metabolized by the liver and is primarily eliminated by the kidneys. While this suggests that dose adjustment for hepatic impairment may not be necessary, any use in patients with existing liver disease requires professional evaluation.

Q: Does Modal need to be taken with food, or can it be taken on an empty stomach?

A: Official patient instructions specifically state that the tablets can be taken either before or after meals. However, the medicine must be taken at least two hours before antacids, which is a critical timing rule for proper absorption.

Q: Can I take Modal if I also take a vitamin supplement?

A: Official safety documents consistently advise informing a healthcare professional about all products being taken. This includes any vitamins, dietary supplements, or herbal remedies, as these can potentially influence the effects or safety profile of the medicine.

Q: Is Modal habit-forming or addictive?

A: The product information discusses the need for gradual withdrawal (tapering) upon discontinuation to prevent adverse effects. However, regulatory-adjacent scientific literature does not commonly categorize this type of antipsychotic medicine as being prone to abuse or addiction.

Q: Can Modal cause mood changes or feel like it alters my personality?

A: Official adverse reaction reports include mental state effects such as agitation and nervousness. Since the therapeutic purpose is to help stabilize disturbed thought and emotional processes, any unexpected mood changes or feeling different should be mentioned to a healthcare professional.

Q: Are there any known interactions between Modal and herbal supplements?

A: Official patient information explicitly advises consulting with a healthcare professional or pharmacist regarding the suitability of any herbal remedies with Modal. Herbal products can potentially influence the effects or safety profile of the medicine.

How should Modal be stored and disposed of?

The storage and disposal of Modal (Sulpiride) must strictly comply with official regulatory labeling to maintain the product's quality and ensure safety.

Storage Requirements

Modal tablets must be stored at a temperature not exceeding 25 C. To prevent product degradation, the medicine must be kept away from direct sunlight and stored in a cool, well-ventilated area. The container must be kept tightly sealed and remain in its original packaging to preserve integrity throughout its labeled shelf-life. A universal safety requirement is to keep Modal out of the sight and reach of children.

Disposal Instructions

Unused or expired Modal must not be thrown away with household waste or wastewater due to environmental considerations. Instead, disposal must follow a pharmaceutical take-back scheme or be performed in accordance with local and national regulations. Consult a pharmacist for guidance on proper disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Modal found in:

A-Z Index: